H&T Presspart’s Inhalation Product Technology Centre (IPTC), our specialist R&D facility, supports our own strategic projects, and those of our pharmaceutical customers.

With our long-standing expertise and in-depth technical understanding of pMDI and dry powder inhaler components and performance, we can help minimise your development cycles, providing a faster route to market.

The IPTC provides you with bespoke strategic and operational project support in three key areas:

With easy access to inhalation devices and components, we can offer fast turnaround times and end-to-end project support, for custom devices and generics.

The key capabilities available from our IPTC include:

  • formulation support, testing and optimisation
  • inhalation device design, development and customisation
  • component or device performance evaluation, screening and optimisation
  • in-vitro characterisation
  • analytical development
  • regulatory support

IPTC Director, Ameet Sule, holds a Masters in Chemistry from Mumbai University and offers over 20 years of experience in the development of respiratory delivery devices, formulations and analytical methods. He and his specialist team operate from the IPTC’s extensive research and laboratory facilities in Blackburn, England.